Alexander Steinkasserer,Matthias Lechmann,Elisabeth Zinser
申请号：
US14306712
公开号：
US09732140B2
申请日:
2014.06.17
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention provides for the use of soluble forms of CD83 and nucleic acids encoding them for the treatment of diseases caused by the dysfunction or undesired function of a cellular immune response involving dendritic cells, T cells and/or B cells. The invention moreover provides soluble CD83 molecules specifically suited for said purpose, antibodies against said specific soluble CD83 proteins and assay methods and kits comprising said antibodies.
